tiprankstipranks
Trending News
More News >
DMCC Speciality Chemicals Limited (IN:DMCC)
:DMCC
India Market

DMCC Speciality Chemicals Limited (DMCC) AI Stock Analysis

Compare
0 Followers

Top Page

IN:DMCC

DMCC Speciality Chemicals Limited

(DMCC)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
₹232.00
▼(-7.90% Downside)
Action:ReiteratedDate:11/21/25
The overall stock score of 61 reflects a strong financial performance, which is the most significant factor. However, bearish technical indicators and a relatively high P/E ratio suggest caution. The lack of earnings call data and corporate events limits further insights.
Positive Factors
Revenue Growth
A 35.7% reported revenue growth indicates durable top-line momentum and stronger market traction. Sustained revenue expansion improves scale economics, funds reinvestment in product and capacity, and supports longer-term margin improvement and strategic initiatives without relying solely on external financing.
Balance Sheet Strength
A strong equity position with moderate debt-to-equity provides financial resilience and borrowing capacity. Manageable leverage combined with solid return on equity allows the company to absorb cyclical shocks, fund organic growth, and maintain investment flexibility over multi-quarter horizons.
Cash Generation / Conversion
Operating cash flow outpacing net income and a favorable free-cash-flow-to-net-income ratio show effective cash conversion. Reliable operating cash generation supports capex, working capital, and shareholder returns from operations, enhancing long-term financial flexibility and reducing dependence on external capital.
Negative Factors
Free Cash Flow Volatility
Inconsistent free cash flow growth introduces execution and funding risk. Volatile FCF can constrain capacity to sustainably fund capex, R&D, or dividends from internal resources, potentially forcing dependence on debt or equity at unfavorable times and limiting strategic optionality.
Margin Instability
Fluctuating net profit margins signal unstable profitability, likely from input cost variability or limited pricing power. Persistent margin swings reduce earnings predictability, hinder long-term planning, and may compress returns on investment if the company cannot consistently pass through costs or improve operational leverage.
Limited Investor Communication
The absence of earnings call disclosures and notable corporate events limits transparency about strategy and execution. Reduced investor communication hampers assessment of management quality and forward guidance, increasing governance and information risk that can persist until regular, detailed disclosures resume.

DMCC Speciality Chemicals Limited (DMCC) vs. iShares MSCI India ETF (INDA)

DMCC Speciality Chemicals Limited Business Overview & Revenue Model

Company DescriptionDMCC Speciality Chemicals Limited, together with its subsidiary, manufactures and sells specialty and commodity chemicals in India and internationally. The company offers sulphur, boron, functional, and life science chemicals. Its products are used in various applications in agro, construction, cosmetic, detergent, dye, electroplating, emulsion, fertilizer, fire retardant, ink, paper, pharmaceutical intermediate, pigment, polymer, textile processing, thermal paper coating, and water treatment markets. The company was formerly known as The Dharamsi Morarji Chemical Company Limited. DMCC Speciality Chemicals Limited was incorporated in 1919 and is headquartered in Mumbai, India.
How the Company Makes Moneynull

DMCC Speciality Chemicals Limited Financial Statement Overview

Summary
DMCC Speciality Chemicals Limited presents a strong financial profile with consistent revenue growth and solid profitability metrics. The balance sheet highlights financial stability with controlled leverage. Cash flow management appears effective, though there is room to stabilize free cash flow growth.
Income Statement
75
Positive
The income statement shows a solid gross profit margin with a consistent increase in total revenue over the years, indicating strong growth. However, the net profit margin fluctuated, showing some instability. The EBIT margin indicates adequate operational efficiency, while EBITDA margin supports good cash flow generation capability.
Balance Sheet
80
Positive
The balance sheet reflects a strong equity position, evident from a favorable equity ratio. The debt-to-equity ratio is moderate, suggesting manageable leverage. The company shows good return on equity, indicating effective use of shareholders' funds, despite some fluctuation in total liabilities.
Cash Flow
70
Positive
The cash flow statement indicates robust operating cash flow relative to net income, though free cash flow has seen some volatility. The free cash flow to net income ratio indicates good cash conversion, but the free cash flow growth rate has been inconsistent, highlighting potential investment risks.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue4.96B4.31B3.26B3.85B3.25B1.96B
Gross Profit1.49B1.33B1.14B1.37B1.28B524.14M
EBITDA649.42M570.16M366.94M387.81M467.11M432.01M
Net Income278.50M215.28M115.89M69.31M213.40M325.79M
Balance Sheet
Total Assets3.75B3.80B3.77B4.01B3.84B2.64B
Cash, Cash Equivalents and Short-Term Investments27.00M51.52M70.63M33.50M29.59M51.84M
Total Debt395.59M470.70M877.11M1.01B933.99M350.80M
Total Liabilities1.41B1.53B1.68B2.03B1.90B905.20M
Stockholders Equity2.34B2.28B2.10B1.98B1.94B1.73B
Cash Flow
Free Cash Flow170.43M310.28M194.33M79.75M-480.71M-150.70M
Operating Cash Flow174.18M380.41M383.74M298.81M506.56M322.45M
Investing Cash Flow-12.05M-66.82M-100.42M-205.59M-984.14M-396.61M
Financing Cash Flow-199.02M-297.83M-271.01M-99.94M461.07M30.22M

DMCC Speciality Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price251.90
Price Trends
50DMA
228.29
Negative
100DMA
249.24
Negative
200DMA
273.18
Negative
Market Momentum
MACD
-3.85
Positive
RSI
46.28
Neutral
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DMCC, the sentiment is Negative. The current price of 251.9 is above the 20-day moving average (MA) of 223.07, above the 50-day MA of 228.29, and below the 200-day MA of 273.18, indicating a bearish trend. The MACD of -3.85 indicates Positive momentum. The RSI at 46.28 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DMCC.

DMCC Speciality Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
₹929.58M18.7110.99%-76.65%-76.77%
66
Neutral
₹1.72B34.221.11%-37.34%-45.55%
63
Neutral
₹7.80B24.500.38%12.35%6.79%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹5.47B25.700.97%40.79%109.95%
58
Neutral
₹5.37B36.572.76%30.68%
49
Neutral
₹1.08B-5.94574.56%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DMCC
DMCC Speciality Chemicals Limited
219.45
-64.17
-22.63%
IN:CHEMBOND
Chembond Chemicals Limited
127.55
-339.07
-72.67%
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
146.50
-34.10
-18.88%
IN:INDOBORAX
Indo Borax & Chemicals Limited
243.05
66.30
37.51%
IN:OCCL
Oriental Carbon & Chemicals Ltd
93.05
-92.25
-49.78%
IN:REGENCERAM
Regency Ceramics Ltd
40.80
-6.31
-13.39%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025